Contineum Therapeutics In... (CTNM)
NASDAQ: CTNM
· Real-Time Price · USD
4.11
0.14 (3.53%)
At close: May 02, 2025, 3:59 PM
4.10
-0.24%
After-hours: May 02, 2025, 04:00 PM EDT
Contineum Therapeutics Class A Common Stock Revenue
Contineum Therapeutics Class A Common Stock reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending December 31, 2024, Contineum Therapeutics Class A Common Stock generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
41
Market Cap
106.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|